{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T16:44:48Z","timestamp":1649177088750},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1007\/s11886-001-0051-8","type":"journal-article","created":{"date-parts":[[2007,8,19]],"date-time":"2007-08-19T11:02:45Z","timestamp":1187521365000},"page":"355-361","source":"Crossref","is-referenced-by-count":1,"title":["Platelet glycoprotein IIb\/IIIa inhibitors for acute coronary syndromes: Initiate treatment early or wait for the catheterization laboratory?"],"prefix":"10.1007","volume":"3","author":[{"given":"David J.","family":"Harnick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Vorchheimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"51_CR1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0733-8651(05)70072-2","volume":"17","author":"DF Kong","year":"1999","unstructured":"Kong DF, Blazing MA, O\u2019Connor CM: The health care burden of unstable angina. Card Clin 1999, 17:247\u2013261.","journal-title":"Card Clin"},{"key":"51_CR2","doi-asserted-by":"crossref","first-page":"VI3","DOI":"10.1002\/clc.4960231103","volume":"23","author":"P Libby","year":"2000","unstructured":"Libby P: Multiple mechanisms of thrombosis complicating atherosclerotic plaques. Clin Cardiol 2000, 23:VI3-VI7.","journal-title":"Clin Cardiol"},{"key":"51_CR3","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM198810273191701","volume":"319","author":"P Theroux","year":"1988","unstructured":"Theroux P, Ouimet H, McCans J, et al.: Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 1988, 319:1105\u20131111.","journal-title":"N Engl J Med"},{"key":"51_CR4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","volume":"308","author":"Antiplatelet Trialists\u2019 Collaboration","year":"1994","unstructured":"Antiplatelet Trialists\u2019 Collaboration: Collaborative overview of randomized trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994, 308:81\u2013106.","journal-title":"Br Med J"},{"key":"51_CR5","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jama.1996.03540100055028","volume":"276","author":"A oler","year":"1996","unstructured":"oler A, Whooley MA, oler J, Grady D: Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina: a meta-analysis. JAMA 1996, 276:811\u2013815.","journal-title":"JAMA"},{"key":"51_CR6","unstructured":"Yusuf S: The CURE Trial results. Presented at the Annual Scientific Sessions of the American College of Cardiology. orlando, FL: March 2001."},{"key":"51_CR7","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1182\/blood.V88.3.907.907","volume":"88","author":"CC Wagner","year":"1996","unstructured":"Wagner CC, Mascelli MA, Neblock S, et al.: Analysis of GP IIb\/ IIIa receptor number and quantification of c7E3 binding to human platelets. Blood 1996, 88:907\u2013914.","journal-title":"Blood"},{"key":"51_CR8","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/S0735-1097(00)00979-7","volume":"36","author":"DP Chew","year":"2000","unstructured":"Chew DP, Moliterno DJ: A critical appraisal of platelet glycoprotein IIb\/IIIa inhibition. J Am Coll Card 2000, 36:2028\u20132035.","journal-title":"J Am Coll Card"},{"key":"51_CR9","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.284.12.1549","volume":"284","author":"DL Bhatt","year":"2000","unstructured":"Bhatt DL, Topol EG: Current role of platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes. JAMA 2000, 284:1549\u20131558. This is an exceptional review article highlighting the importance of GP IIb\/IIIa inhibitors in acute coronary syndromes, with a comprehensive summary of trials with GP IIb\/IIIa in PCI and in the medical management of UA\/NQMI. Includes dosing and adverse effects of GP IIb\/IIIa and recommendations on proper treatment strategy.","journal-title":"JAMA"},{"key":"51_CR10","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJM199404073301402","volume":"330","author":"The EPIC Investigators","year":"1994","unstructured":"The EPIC Investigators: Use of a monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994, 330:956\u2013961.","journal-title":"N Engl J Med"},{"key":"51_CR11","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJM199706123362401","volume":"336","author":"The EPILoG Investigators","year":"1997","unstructured":"The EPILoG Investigators: Platelet glycoprotein IIb\/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997, 336:1689\u20131696.","journal-title":"N Engl J Med"},{"key":"51_CR12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(98)06113-3","volume":"352","author":"The EPISTENT Investigators","year":"1998","unstructured":"The EPISTENT Investigators: Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb\/IIIa blockade. Lancet 1998, 352:87\u201392.","journal-title":"Lancet"},{"key":"51_CR13","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0140-6736(96)10172-0","volume":"349","author":"The IMPACT Investigators","year":"1997","unstructured":"The IMPACT Investigators:Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Integrilin to Minimise Platelet Aggregation and Coronary Thrombosis-II. Lancet 1997, 349:1422\u20131428.","journal-title":"Lancet"},{"key":"51_CR14","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/S0140-6736(00)03400-0","volume":"356","author":"The ESPRIT Investigators","year":"2000","unstructured":"The ESPRIT Investigators: Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomized, placebo-controlled trial. Lancet 2000, 356:2037\u20132044.","journal-title":"Lancet"},{"key":"51_CR15","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJM200106213442502","volume":"344","author":"EJ Topol","year":"2001","unstructured":"Topol EJ, Moliterno DJ, Herrmann HC, et al.: Comparison of two platelet glycoprotein IIb\/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. N Engl J Med 2001, 344:1879\u20131887.","journal-title":"N Engl J Med"},{"issue":"suppl II","key":"51_CR16","first-page":"II88","volume":"82","author":"RK Myler","year":"1990","unstructured":"Myler RK, Shas RE, Stertzer SH, et al.: Unstable angina and coronary angioplasty. Circulation 1990, 82(suppl II):II88-II95.","journal-title":"Circulation"},{"key":"51_CR17","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/01.CIR.89.4.1545","volume":"89","author":"The TIMI IIIB Investigators","year":"1994","unstructured":"The TIMI IIIB Investigators: Effects of tissue plasminogen activator and comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Circulation 1994, 89:1545\u20131556.","journal-title":"Circulation"},{"key":"51_CR18","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1056\/NEJM199806183382501","volume":"338","author":"WE Boden","year":"1998","unstructured":"Boden WE, O\u2019Rourke RA, Crawford MH, et al. for the Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators: outcomes in patients with acute non-Q-wave MI randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med 1998, 338:1785\u20131792.","journal-title":"N Engl J Med"},{"key":"51_CR19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(97)11162-X","volume":"352","author":"S Yusuf","year":"1998","unstructured":"Yusuf S, Flather M, Pogue J, et al.: Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation: oASIS (organisation to Assess Strategies for Ischaemic Syndromes) Registry Investigators. Lancet 1998, 352:507\u2013514.","journal-title":"Lancet"},{"key":"51_CR20","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","volume":"344","author":"CP Cannon","year":"2001","unstructured":"Cannon CP, Weintraub WS, Demopoulos LA, et al.: Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban. N Engl J Med 2001, 344:1879\u20131894.","journal-title":"N Engl J Med"},{"key":"51_CR21","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0140-6736(99)07349-3","volume":"354","author":"FRISC II Investigators","year":"1999","unstructured":"FRISC II Investigators: Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomized multicentre study. Lancet 1999, 354:708\u2013715.","journal-title":"Lancet"},{"key":"51_CR22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(00)02427-2","volume":"356","author":"L Wallentin","year":"2000","unstructured":"Wallentin L, Lagerqvist B, Husted S, et al.: outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomized trial. Lancet 2000, 356:9\u201316.","journal-title":"Lancet"},{"key":"51_CR23","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1056\/NEJM199805213382103","volume":"338","author":"The PRISM Investigators","year":"1998","unstructured":"The PRISM Investigators: A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med 1998, 338:1498\u20131505.","journal-title":"N Engl J Med"},{"key":"51_CR24","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199808133390704","volume":"339","author":"The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and symptoms (PRISM-PLUS) Study Investigators","year":"1998","unstructured":"The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and symptoms (PRISM-PLUS) Study Investigators: Inhibition of the platelet Glycoprotein IIb\/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 1998, 339:436\u2013443.","journal-title":"N Engl J Med"},{"key":"51_CR25","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199808133390704","volume":"339","author":"The PURSUIT Investigators","year":"1998","unstructured":"The PURSUIT Investigators: Inhibition of platelet glycoprotein IIb\/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 1998, 339:436\u2013443.","journal-title":"N Engl J Med"},{"key":"51_CR26","first-page":"I359","volume":"98","author":"RA Harrington","year":"1998","unstructured":"Harrington RA, Lincoff MA, Berdan LG, et al.: Maintenance of clinical benefit at six-months in patients treated with the platelet Glycoprotein IIb\/IIIa inhibitor eptifibatide versus placebo during an acute ischemic coronary event. Circulation 1998, 98:I359.","journal-title":"Circulation"},{"key":"51_CR27","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/01.CIR.101.7.751","volume":"101","author":"NS Kleiman","year":"2000","unstructured":"Kleiman NS, Lincoff AM, Flaker GC, et al.: Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes: PURSUIT Investigators. Circulation 2000, 101:751\u2013757.","journal-title":"Circulation"},{"key":"51_CR28","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1161\/01.CIR.97.24.2386","volume":"97","author":"The PARAGoN Investigators","year":"1998","unstructured":"The PARAGoN Investigators: International, randomized, controlled trial of lamifiban (a platelet Glycoprotein IIb\/IIIa inhibitor), heparin, or both in unstable angina. Circulation 1998, 97:2386\u20132395.","journal-title":"Circulation"},{"key":"51_CR29","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(96)10452-9","volume":"349","author":"The CAPTURE Investigators","year":"1997","unstructured":"The CAPTURE Investigators: Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study. Lancet 1997, 349:1429\u20131435.","journal-title":"Lancet"},{"key":"51_CR30","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/01.CIR.100.20.2045","volume":"100","author":"E Boersma","year":"1999","unstructured":"Boersma E, Akkerhuis M, Theroux P, et al.: Platelet Glycoprotein IIb\/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: Early benefit during medical treatment only, with additional protection during percutaneous coronary intervention. Circulation 1999, 100:2045\u20132048. This article elaborates the benefits of GP IIb\/IIIa in the period before and immediately after PCI. First review to illustrate the importance of GP IIb\/IIIa as a bridge to invasive strategies.","journal-title":"Circulation"},{"key":"51_CR31","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(00)05060-1","volume":"357","author":"The GUSTo IV-ACS Investigators","year":"2001","unstructured":"The GUSTo IV-ACS Investigators: Effect of glycoprotein IIb\/ IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularization: the GUSTo IV-ACS randomised trial. Lancet 2001, 357:1915\u20131924.","journal-title":"Lancet"},{"key":"51_CR32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/01.CIR.102.1.118","volume":"102","author":"CW Hamm","year":"2000","unstructured":"Hamm CW, Braunwald E: A classification of unstable angina revisited. Circulation 2000, 102:118\u2013122.","journal-title":"Circulation"},{"key":"51_CR33","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","volume":"284","author":"EM Antman","year":"2000","unstructured":"Antman EM, Cohen M, Bernink PJLM: The TIMI risk score for unstable angina\/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000, 284:835\u2013842.","journal-title":"JAMA"},{"key":"51_CR34","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0735-1097(00)00889-5","volume":"36","author":"E Braunwald","year":"2000","unstructured":"Braunwald E, Antman EM, Beasley JW, et al.: ACC\/AHA guidelines for unstable angina. J Am Coll Cardiol 2000, 36:970\u20131062.","journal-title":"J Am Coll Cardiol"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-001-0051-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-001-0051-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-001-0051-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,26]],"date-time":"2020-04-26T00:13:13Z","timestamp":1587859993000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-001-0051-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["51"],"URL":"https:\/\/doi.org\/10.1007\/s11886-001-0051-8","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}